Orchid posts good Q3 performance
16 Jan 2004
Chennai: The city based bulk drug major Orchid Chemicals & Pharmaceuticals has closed its third quarter ending 31st December 2003 with a turnover of Rs.170.90 crore and a net profit of Rs. 8.41 crore. The figures for the corresponding period last year were Rs.128.28 crore and Rs.3.72 crore respectively.
The company's turnover and operating income for the nine months ended December 31, 2003 stood at Rs 505.66 crore as compared to Rs 346.45 crore in the corresponding period last fiscal. Net profit after deferred tax for the nine months was Rs 23.27 crore compared to Rs 9.52 crore registered during the same period of the last fiscal.
During the quarter, the US discovery JV (Bexel Pharmaceuticals) progressed well on its novel anti-diabetic molecule (BLX-1002). Following the successful completion of pre-clinical tests and evaluation of the results and clinical protocols by the Independent Ethics Committee (IEC), BLX-1002 is now in Phase I human clinical trials in Europe. BLX-1002 is an orally active small molecule for treatment of Type-2 diabetes. The molecule is distinctive in its class for not only its exceptional efficacy and safety, but also its unique anti-weight gain property.
Orchid's NDD research program in Chennai has been developing more lead molecules in the area of anti-infectives and anti-inflammation segments which have shown good promise in in-house pre clinical safety and efficacy tests.
Latest articles
Featured articles
The remarkable Ratan Tata
By Kiron Kasbekar | 23 Oct 2024
One newspaper report of Ratan Tata’s passing away showed an old photo of him climbing into the cockpit of a Lockheed Martin F-16 fighter.
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation